138 related articles for article (PubMed ID: 5151819)
1. Forty-four months' experience in the treatment of leprosy with clofazimine (Lamprene (Geigy)).
Schulz EJ
Lepr Rev; 1971 Sep; 42(3):178-87. PubMed ID: 5151819
[No Abstract] [Full Text] [Related]
2. Controlled clinical trial of clofazimine in untreated lepromatous leprosy.
Karat AB; Jeevaratnam A; Karat S; Rao PS
Br Med J; 1971 Nov; 4(5786):514-6. PubMed ID: 4942741
[TBL] [Abstract][Full Text] [Related]
3. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
[No Abstract] [Full Text] [Related]
4. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS.
Tolentino JG; Rodriquez JN; Abalos RM
Int J Lepr Other Mycobact Dis; 1974; 42(4):416-418. PubMed ID: 4617720
[No Abstract] [Full Text] [Related]
5. Double-blind controlled clinical trial of clofazimine in reactive phases of lepromatous leprosy.
Karat AB; Jeevaratnam A; Karat S; Rao PS
Br Med J; 1970 Jan; 1(5690):198-200. PubMed ID: 4904935
[TBL] [Abstract][Full Text] [Related]
6. Treatment of moderately severe erythema nodosum leprosum with clofazimine--a controlled trial.
Helmy HS; Pearson JM; Waters MF
Lepr Rev; 1971 Sep; 42(3):167-77. PubMed ID: 4339652
[No Abstract] [Full Text] [Related]
7. Antibacterial effects of G 30'320 Geigy (B663) in lepromatous leprosy.
Hastings RC; Trautman JR; Mansfield RE
Dermatol Int; 1969; 8(1):21-7. PubMed ID: 5343403
[No Abstract] [Full Text] [Related]
8. Efficacy of clofazimine in the prophylaxis and suppression of reactive phases of lepromatous leprosy.
Karat AB; Jeevaratnam A; Karat S; Rao PS
Int J Lepr Other Mycobact Dis; 1971; 39(4):838-41. PubMed ID: 5170472
[No Abstract] [Full Text] [Related]
9. Lamprene: first results of treatment in the Netherlands in a group of 6 leprosy patients.
Hogerzeil LM
Dermatologica; 1971; 143(6):339-44. PubMed ID: 5150817
[No Abstract] [Full Text] [Related]
10. [. 663 (G 30320 "Geigy"), a new chemotherapeutic agent against leprosy].
Vischer WA
Schweiz Med Wochenschr; 1967 Mar; 97(10):308. PubMed ID: 5585384
[No Abstract] [Full Text] [Related]
11. Clofazimine (B663, Geigy) in leprosy reactions.
Smith RB
Australas J Dermatol; 1972 Apr; 13(1):31-5. PubMed ID: 5082494
[No Abstract] [Full Text] [Related]
12. The treatment of leprosy.
Waters MF
Tubercle; 1983 Sep; 64(3):221-32. PubMed ID: 6356539
[No Abstract] [Full Text] [Related]
13. Controlled drug trial of B.663 compared with DDS. Preliminary (48 week) report.
Tolentino JG; Rodriquez JN; Abalos RM
Int J Lepr Other Mycobact Dis; 1971; 39(3):738-41. PubMed ID: 5169924
[No Abstract] [Full Text] [Related]
14. Management of steroid-dependency with clofazimine (Lamprene or B 663 (Geigy)).
Morgan J
Lepr Rev; 1970 Oct; 41(4):229-32. PubMed ID: 5515679
[No Abstract] [Full Text] [Related]
15. Treatment of Hansen's disease.
Trautman JR
Cutis; 1976 Jul; 18(1):62-5. PubMed ID: 1017285
[No Abstract] [Full Text] [Related]
16. G 30 320 or B 663--lampren (Geigy).
Waters MF
Lepr Rev; 1969 Jan; 40(1):21-47. PubMed ID: 4888382
[No Abstract] [Full Text] [Related]
17. Treatment with thalidomide in steroid dependency and neuritis.
Theophilus S
Lepr India; 1980 Jul; 52(3):423-8. PubMed ID: 7206639
[TBL] [Abstract][Full Text] [Related]
18. Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.
Levy L; Shepard CC; Fasal P
Am J Trop Med Hyg; 1972 May; 21(3):315-21. PubMed ID: 4554496
[No Abstract] [Full Text] [Related]
19. Possible incompatibility of dapsone with clofazimine in the treatment of patients with erythema nodosum leprosum.
Imkamp FM; Anderson R; Gatner EM
Lepr Rev; 1982 Jun; 53(2):148-9. PubMed ID: 7098753
[No Abstract] [Full Text] [Related]
20. Clofazimine and dapsone--a combination therapy in erythema nodosum leprosum syndrome.
Dutta RK
Lepr India; 1980 Apr; 52(2):252-9. PubMed ID: 7453140
[No Abstract] [Full Text] [Related]
[Next] [New Search]
